Thoratec Laboratories Corporation

6035 Stoneridge Drive
Pleasanton
CA
94583
USA
Phone: 
925-847-8600
Fax: 
925-847-8574
http://www.thoratec.com

Related Articles

Ventricular Assist Devices (VAD)

ECMO May Become the pVAD of the Future
Thoratec Recalls HeartMate II LVAD Due to Outflow Graft Kinks
VAD Maker Thoratec Acquires Levitronix, Pediatric Device
Texas Children's Hospital Explants VAD, Sends Heart Failure Teen Home With a Healed Heart
New Study Shows Viability of Heart Pumps for Older Heart-Failure Patients
SynCardia May Be for Sale in Next 12-24 Months
Thoratec Acquires Catheter-Based Heart Pump Technology
FDA Clears VAD as Destination Therapy for Heart Failure
Thoratec, HeartWare Terminate Proposed Merger
U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International
VAD Maker Thoratec Acquires HeartWare for $282 Million
Thoratec Issues Warning For Certain HeartMate II VADs
Could Heart Transplants Become a Thing of the Past?
FDA Approves HeartMate II for Bridge-To-Transplantation
FDA Approves HeartMate II for Bridge-To-Transplantation
Smaller Heart Pump Bridges Time to Transplant for More Women
FDA Advisory Panel Reviews Thoratec’s HeartMate II PMA
Thoratec Receives OK to Add 60 More Patients to HeartMate II BTT Trial
Thoratec’s HeartMate ll Pivotal Trial Data Presented
Medicare May Pump Big Dollars to Thoratec

Cath Lab

ECMO May Become the pVAD of the Future
Thoratec Announces the First Human Use of HeartMate PHP

Hemodynamic Support Devices

ECMO May Become the pVAD of the Future

Heart Failure Treatments

Thoratec Announces the First Human Use of HeartMate PHP
Thoratec Recalls HeartMate II LVAD Due to Outflow Graft Kinks
VAD Maker Thoratec Acquires Levitronix, Pediatric Device
Texas Children's Hospital Explants VAD, Sends Heart Failure Teen Home With a Healed Heart
New Study Shows Viability of Heart Pumps for Older Heart-Failure Patients

Cardiovascular Surgery

VAD Maker Thoratec Acquires Levitronix, Pediatric Device

Clinical Trial/Study

New Study Shows Viability of Heart Pumps for Older Heart-Failure Patients
Could Heart Transplants Become a Thing of the Past?

Artificial Heart

SynCardia May Be for Sale in Next 12-24 Months

Cardiac Resynchronization Therapy Devices (CRT)

Thoratec, HeartWare Terminate Proposed Merger

General Cardiology

Thoratec Issues Warning For Certain HeartMate II VADs
Could Heart Transplants Become a Thing of the Past?

Cardiology Products

Thoratec Issues Warning For Certain HeartMate II VADs
Could Heart Transplants Become a Thing of the Past?

Catheters

Thoratec’s HeartMate II Trial Enrollment Advances